Hudkræftklinikken.dk ApS: Financial statements 2020
CVR: 38219960
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Hudkræftklinikken.dk ApS (CVR 38219960) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,731,389 and a net result of DKK 166,791 compared with DKK -819,454 the year before. That is a decrease of 18.2% compared with the year before. Equity in the 2020 report amounted to DKK 2,404,203. The solvency ratio was 96.7%.
- Gross Profit
- DKK 1,731,389
- Profit/Loss
- DKK 166,791
- Equity
- DKK 2,404,203
- Total Assets
- DKK 2,485,232
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.7M | 167K | 2.4M | - |
| 2019 | - | 2.1M | -819K | 2.2M | - |
| 2018 | - | 1.6M | 58K | 3.3M | - |
Official annual report
How creditworthy is Hudkræftklinikken.dk ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Hudkræftklinikken.dk ApS has published its annual report for 2019. Gross profit came to DKK 2,116,482, and the net result was DKK -819,454.
About Hudkræftklinikken.dk ApS
Hudkræftklinikken.dk ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Speciallægers aktiviteter. The company was previously named Hudkræftklinikken.dk Anpartsselskab. The management consists of Bolette Birch Bengtsen. The board consists of Robert Birger Birch (chair), Kent Stevens Larsen and Martin Glud. The company's owners include Birch Bengtsen Invest ApS, PHOENIX CAPITAL ApS and M.Glud holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,898,097 and a net result of DKK -210,331 compared with DKK 9,266 the year before. Equity in the 2025 report amounted to DKK 757,000.